You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE
SBC: Alcohol Self-control Program Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
PORTABLE MULTIMEDIA FOR FAMILY CAREGIVER TRAINING
SBC: American Research Corporation of Virginia Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS
SBC: Argonex, Inc. Topic: N/AIn the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...
SBIR Phase I 1997 Department of Health and Human Services -
TACTILE GRAPHIC PRINTER PROJECT (TGPP)
SBC: Automated Functions, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
EVALUATION OF CRL1072 FOR TREATMENT OF MYCOBACTERIUM AV
SBC: CYTRX CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
A2a--Adenosine Agonist for Cardiovascular Imaging
SBC: Discovery Therapeutics, Inc. Topic: N/AAdenosine produces coronary vasodilation through activation of A-2a adenosine receptors. However adalso acts at A1 adenosine receptors to slow atrioventricular conduction and when injected into man ican be blocked with A1 receptor antagonists. DTI has synthesized a number of adenosine analogs that2a subtype of adenosine receptor and have identified WRC-0470 as a potent selective short acting corou ...
SBIR Phase I 1995 Department of Health and Human Services -
ADENOSINE ANTAGONIST FOR CARDIOPULMONARY RESUSCITATION
SBC: Discovery Therapeutics, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
IMMUNOGLOBULIN COATINGS TO PREVENT CATHETER INFECTION
SBC: GAMMA-A TECHNOLOGIES, INC. Topic: N/ACatheters are one of the most commonly used biomaterial implants, (200 million annually in the U.S.). In long term use as for vascular central lines, the urinary tract and peritoneal dialysis, catheters are particularly susceptible to infection. These infections are resistant to antibiotic treatment and persist until removal of the device. Utilizing the concept of Passive Local Immunotherapy, (PL ...
SBIR Phase I 1997 Department of Health and Human Services -
CD ROM BASED CANCER PREVENTION PROGRAM FOR THE WORKSITE
SBC: ISA ASSOCIATES INC Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Hera-An Expert System for Preventive Care
SBC: Mvbs, Inc. Topic: N/AWe will continue development of Hera¿, a microcomputer- based expert system that takes a preventivehistory from a lay user and makes recommendations to the user about various preventive health activirecommendations, tailored to the user's history, are based on authoritative practice guidelines storbase. The user is strongly urged to discuss the recommendations with a physician or other trained he ...
SBIR Phase I 1995 Department of Health and Human Services